Pacira BioSciences ( NASDAQ: PCRX ) on Thursday announced that the U.S. Centers for Medicare and Medicaid Services (CMS) issued a product-specific J-code for its non-opioid pain therapy Exparel for purposes of reimbursement.
J0666, the J-Code issued for Exparel, is expected to take effect on.
